Table 2 Linear regression of the subgroups of each class
Average annual growth rate | Proportion | Coefficient for the year of publication (95% CI) | p-value | Adjusted R2 | Adjusted R2 (model with year squared) | |
|---|---|---|---|---|---|---|
All | 20.99% | 100% | 72.01 (56.8–78.3) | < 0.001 | 0.83 | 0.93 |
Primary research fields | ||||||
Certain infectious or parasitic diseases | 42.84% | 9.84% | 3.46 (1.92–4.90) | < 0.001 | 0.514 | 0.697 |
Mental, Behavioral, or Neurodevelopmental disorders | 39.28% | 16.27% | 6.23 (4.28–8.19) | < 0.001 | 0.686 | 0.932 |
Neoplasm | 42.41% | 27.66% | 9.8377 (7.498–12.18) | < 0.001 | 0.793 | 0.955 |
Diseases of the Circulatory System | 49.04% | 11.27% | 3.78 (2.918–4.648) | < 0.001 | 0.805 | 0.912 |
Text sources | ||||||
Electronic Medical/Health and Similar databases | 25.41% | 57.12% | 30.87 (23.33–38.41) | < 0.001 | 0.784 | 0.931 |
Published Medical Evidence | 31.52% | 33.84% | 13.07 (11.247–14.9) | < 0.001 | 0.918 | 0.935 |
Social media + Website | 51.03% | 4.13% | 3.133 (1.86–4.41) | < 0.001 | 0.56 | 0.874 |
Omics databases | 65.08% | 4.91% | 1.66 (1.07–2.25) | < 0.001 | 0.627 | 0.637 |
Context of use | ||||||
Bioinformatics | 69.65% | 15.66% | 5.26 (4.23–6.29) | < 0.001 | 0.849 | 0.853 |
Clinical Decision Support and Similar fields | 32.12% | 25.45% | 19.25 (13.42–25.09) | < 0.001 | 0.7 | 0.94 |
NLP Method Advancement | 31.76% | 10.47% | 7.09 (4.83–9.35) | < 0.001 | 0.678 | 0.896 |
Other Medical Fields | 19.44% | 48.42% | 21.72 (17.486–25.96) | < 0.001 | 0.851 | 0.888 |